WHO approval of Sinovac COVID-19 jab seen as 'advantage' for PhilippinesMANILA, Philippines — The World Health Organization’s approval of the COVID-19 vaccine developed by Sinovac Biotech is an “advantage” for the Philippines, the Department of Health said Wednesday. Sinovac’s two-dose jab CoronaVac accounts for the bulk of the country’s vaccine supply. Since February, the Philippines has received 5.5 million CoronaVac doses, of which one million were donated by the Chinese government. WHO’s emergency use listing (EUL) gives countries assurance that the vaccine has met international standards, infectious disease specialist Anna Ong-Lim said. “It’s going to be something of an advantage because the vaccines being used here are mostly Sinovac and it can be recognized by other countries as well,” she added.

Source: Philippine Star June 02, 2021 09:56 UTC